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ABSTRACT
Cutaneous leishmaniasis (CL) is a widespread tropical infection which has a high incidence rate in 
Iran. Leishmania tropica, the causative agent of anthroponotic cutaneous leishmaniasis (ACL), and 
Leishmania major, which causes zoonotic cutaneous leishmaniasis (ZCL), are endemic in various 
parts of Iran with a high incidence rate. The aim of this study was to evaluate the reappraisal of the 
diagnosis and epidemiology of CL in Iran, by different clinical, parasitological and molecular as-
says among patients suspected of CL referred to the Department of Parasitology, at the Pasteur 
Institute of Iran during 2006-2009. Two hundred samples from patients with ulcerative skin lesions 
were collected, clinical analyses were applied, data questionnaire was completed and samples were 
examined for CL by using both direct microscopic and culture methods. Moreover, PCR assay was 
applied for detection of Leishmania species in CL isolates resulting from parasitological assay. Clini-
cal observation revealed that the majority (58%) of lesions was single; double lesions were observed 
in 22% of patients, and only 20% of CL had multiple lesions. Out of 200 patients, Leishman body 
was observed in 77 samples (38.5%) by direct smear and 40% by cultivation assay. Most patients 
(21.3%) had a travel history to the Isfahan province, one of the most important endemic areas of CL 
located in center of Iran. PCR assay by kDNA indicated 32 and 18 out of 50 isolates respectively had 
similar patterns with standard L. major and L. tropica. In conclusion, clinical manifestations and an 
appropriate diagnostic assay with a parallel molecular characterization of CL may lead to a screening 
evaluation of disease, prognosis, treatment and control strategies. 
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INTRODUCTION
Leishmaniasis is endemic in 88 countries 
throughout Africa, Asia, Europe, and North 
and South America. There are estimated 12 
million cases worldwide, with one million 
new cases each year.1,2 At least 21 species and 
subspecies of Leishmania have been recorded 
as being infective to humans, many of which 
cause extensive morbidity and are responsible 
for a wide spectrum of clinical symptoms. Cu-
taneous leishmaniasis (CL) is a common skin 
disease in the Middle East region affecting all 
ages and both sexes.3
Both CL and visceral leishmaniasis (VL) 
occur in different parts of Iran.4 Leishmania 
(L.) tropica, the causative agent of anthro-
ponotic cutaneous leishmaniasis (ACL), and L. 
major, which causes zoonotic cutaneous leish-
maniasis (ZCL), are endemic in various regions 
of Iran with a high incidence rate.5,6 CL is still 
considered an important health problem in 
many areas of the world, especially the Eastern 
Mediterranean region, and almost all countries 
of the Middle East, including Iran.7,8 In Iran the 
disease prevalence is high in some foci, includ-
ing Isfahan,9 Shiraz,10 Khorasan,11 Khuzestan 
and Kerman12 provinces.
Correct diagnosis and characterization of 
the particular parasite is important for prog-
nostic evaluation and for prescribing appropri-
ate treatment.13 According to routine assays, 
diagnosis is based primarily on clinical symp-
toms, microscopic observation of parasites in 
stained smears, and/or cultivation of promas-
tigotes.14 A timely and defi nitive diagnosis of 
CL is important for initiating appropriate clin-
ical management and treatment of this disease. 
Microscopy may be the simplest method of 
achieving this, but the high rate of undiagnosed 
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cases associated with this method underscores its defi ciency. 
The only rapid method for the diagnosis of CL is the PCR; 
however, it is not yet available outside the research settings 
and remains expensive for fi eld deployment. Diagnosis of CL 
by cultivation in liquid media has several advantages, mainly 
the possibility of examining the entire sample collected in 
a closed system for the emergence of a few motile promas-
tigotes. For decades, blood-based biphasic media of various 
formulations have been used for this purpose with variable 
degrees of success. The culture often turns out positive when 
inoculated with lesion aspirates from CL suspected patients 
having a large number of amastigotes. Also, a prolonged 
incubation is often required for a positive result. Effi cient 
culture techniques for diagnosis of leishmaniasis require an 
in vitro environment for rapid conversion of a small number 
of amastigotes into a population of motile promastigotes 
visible by microscopy.15
This study was performed to evaluate the reappraisal of 
the diagnosis and epidemiology of CL in Iran, by different 
clinical, parasitological and molecular assays among CL pa-
tients suspected referred to the Department of Parasitology, 
at the Pasteur Institute of Iran, Tehran, from 2006 to 2009. 
The parasitological techniques (microscopy and culture) will 
be applied as gold standard for CL diagnosis; PCR assay was 
also used for detection of CL species in collected samples. 
MATERIALS AND METHODS
Study population
This descriptive study was carried out with patients clinical-
ly suspected of having CL, who were referred to the Depart-
ment of Parasitology, at the Pasteur Institute of Iran, Tehran, 
for laboratory confi rmation. The diagnosis of CL was based 
on clinical observation, positive smear and culture assay. 
For each case having cutaneous lesions, a questionnaire was 
completed to record the necessary information including 
name, age, gender, address, location of ulcer on the body, 
data and place of acquiring the disease, previous travel his-
tory and work address. A total number of 200 patients with 
skin lesions, suspected of CL were examined during the pe-
riod of 2006-2009.
Samples and smears
Generally, samples were obtained from those ulcers which 
showed the most indurate margins. The lesions were cleaned 
from debris with normal saline. Purulent or necrotic ulcers 
were treated with particular care and debris removed before 
sampling. According to clinical history, none of the patients had 
received any antileishmanial chemotherapy prior to diagnosis. 
Samples for parasitological diagnosis were dermal scraping 
of the active indurate margins of lesions or dermal scrap-
ing of the bottoms of the ulcer. Skin scrapings from the le-
sion were obtained and smears prepared on a slide, stained 
with Giemsa and examined microscopically for presence of 
amastigotes. Bacterial contamination of Leishmania cultures 
was minimized by cleaning lesions with 70% methanol and 
local debridement before obtaining specimens. At least two 
Giemsa-stained slides for each patient were prepared for mi-
croscopic examination. 
Culture method
The samples were aspirated from the edge of the skin le-
sions and cultured in liquid phase (normal saline) of Novy 
Macneal Nicolle (NNN) media. The culture was incubated 
at 25°C and checked for growth of Leishmania promastig-
otes and supervised every day using an inverted microscope 
for 28 days. Penicillin-G and Streptomycin were added to 
the phosphate buffered saline (PBS) solution utilized in the 
NNN media culture.16-18
DNA extraction
DNA extraction and PCR assay were performed on promas-
tigotes isolated from NNN media. The mass cultured pro-
mastigotes were harvested by centrifugation (3,000 rpm) 
at 4°C for 10 min and washed three times in cold sterile 
PBS (pH 7.2). DNA was extracted by DNG-plus extraction 
Kit (Cinnagen Co., Iran) according to the manufacturer’s 
manual. Brieﬂ y, the pellet was mixed in 400 µL DNG-plus 
solution and vortexed for 15-20 s. Three hundred microlit-
ers of isopropanol were added and mixed by vortexing, and 
the specimen was centrifuged at 12,000 rpm for 10 min. The 
tube was decanted by gently inverting and placed on tissue 
paper for 2-3 s downward. One milliliter of 75% ethanol 
was added to the pellet, mixed by 3-5 s vortexing and centri-
fuged at 12,000 rpm tor 5 min. The ethanol was poured off 
completely, and the pellet dried at 65°C for 5 min. The DNA 
pellet was dissolved in 50 µL of sterile distilled water and 
incubated in a water bath at 65°C for 5 min and stored at 
4°C until use.19
PCR assay
Leishmania isolates were detected according to the kit man-
ufacturer company by using Leishmania spp. PCR Deter-
mination kit (Cinnagen Co, Iran). This kit is designed for 
qualitative detection of Leishmania spp. kinetoplast DNA by 
PCR. Assay was performed according to the manufacturer’s 
protocol with the fi nal volume of 25 µL of each PCR reac-
tion. PCR amplifi cation was carried out in a DNA Thermal 
Cycler (Master cycler gradient, Eppendorf, Hamburg, Ger-
many) based on the following conditions: initial denatura-
tion (95°C, 3 min; 63°C, 30 s; 72°C, 60 s) 1 cycle followed 
by 35 cycles including denaturation (93°C, 20 s), annealing 
(63°C, 20 s) and extension (72°C, 40 s). Finally, 10 µL of am-
plifi ed samples without adding loading buffer were loaded 
in a 2% agarose gel containing 0.5 mg/mL ethidium bro-
mide in electrophoresis and the products were visualized by 
UV transillumination.
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RESULTS
Frequency of cutaneous leishmaniasis according to 
age groups and gender
Leishmania amastigotes were detected by microscopic observa-
tion in 77 cases (38.5%) out of 200 patients; however the NNN 
culture led to the growth of promastigotes in 80 samples (40%). 
Association of CL infection and gender was observed in 63.8% 
(51) males and 36.2% (29) females. Although the highest rate 
(31.3%) of infection was recorded in 21-30 years age group, the 
lowest rate (10%) was represented by the 31-40 years age group.
Frequency of CL lesion number
Number of lesions varied with single lesions being ob-
served in the majority of patients (58%), appearing as a 
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Table 1. Frequency of CL by place of residence and travel history 
Name of province Endemic area Travelling  Residence Number of isolates % 
Fars Shiraz  5 1 6 7.5
Ilam Dehloran 2 - 2 2.5
Isfahan Isfahan & Kashan 17 - 17 21.25
Kerman Kerman & Bam 7 3 10 12.5
Khorasan Mashhad & Sabzevar 9 3 12 15
Khuzestan Ahwaz 1 1 2 2.5
Semnan Damghan 8 1 9 11.25
Tehran  Tehran & Varamin  4 2 6 7.5
Yazd Yazd  5 - 5 6.25
Hormozgan Bandar Abass 1 - 1 1.25
Other countries Afghanistan 10 - 10 12.5
Total 11 Locations 11 Endemic areas 69 11 80 100
Figure 1: Single and multiple lesions in patients with CL in Iran.
round papular plaque with a 4-80 mm diameter. In ad-
dition, double lesions were seen in 22% of cases; finally, 
20% of patients presented multiple lesions between 3-7 
mm (Figure 1).
Frequency of CL by place of residence and travel 
history
Residence, workplace, travel history of patients were 
important data for determining the location where the 
infections might have taken place. The highest propor-
tion of infections (21.25%) was recorded in patients 
who were traveling or living in Isfahan and Kashan. 
Lowest percentage (1.25%) was reported in patients 
living in Hormozgan, Ilam and Khuzestan provinces 
(Table 1).
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CL lesion location in body
The samples were taken from different sites of suspected 
lesions. Hand and arm were the most commonly affected 
sites (40.0%), while other major sites of lesion location 
were face and neck (37.5%). Detailed location of lesions is 
shown in Table 2.
DISCUSSION
Findings of this research revealed that Leishmania para-
site was less detected by microscopic observation (38.5%) 
than by culture method (40%). This is in agreement with 
authors’ previous report,18 but not with Kumar et al. who 
indicated that direct microscopy or parasite culture alone 
detected respectively 65.5% and 48.2% of the positive sam-
ples.20
CL infection was more prevalent among males 
(63.8%) than females (36.2%). Previous reports con-
firmed the same results indicating that males are more 
commonly infected than females, most likely because of 
their exposure, possibly as a result of occupational contact 
with the outdoor sand ﬂ y vectors.18-21 Moreover, the highest 
proportion of infection (31.3%) was recorded in 21-30 years 
age group, and the lowest (10%) was in the 31-40 years age 
group, which is in agreement with previous reports indi-
cating more exposure as a result of educational and oc-
cupational situations.18-21
According to the number of lesions in the patients, sin-
gle lesions were more common (58%) than both double 
(22%) or multiple lesions (20%), which is consistent with 
a previous report by Talari et al.7 that showed 69.7% had 
only one lesion.22 Multiple biting habits by the sand ﬂ y 
could explain the fi nding of about 42% of patients having 
more than one skin lesion. 
Knowing the geographical location of infection acquisi-
tion is important in order to focus on epidemiological pat-
tern of disease. The majority of patients were resident or at 
least had a travel history to Isfahan and Kashan (21.25%), 
central Iran, while a few patients were traveling or living in 
Hormozgan (1.5%) and Khuzestan provinces (2.5%), south 
Iran or in Ilam province (2.5%), west part Iran. There is 
an agreement between our fi ndings with previous reports 
which confi rm disease dissemination for many years in the 
rural areas of Kashan, specially in Abouzeidabad. This might 
be due to the high transmission rate maintained by the pres-
ence of both vector (Phlebotomus papatasi) and reservoir 
(Rhombomys opimus) in those areas.7,18 However some stud-
ies have indicated different results.23 Two species of Leish-
mania are involved in CL infections in Iran. L. major for 
ZCL and L. tropica for ACL. ACL has a disperse frequency 
whereas ZCL is found in many rural foci in the north, east 
and south of Iran.7,24
Hand and arm were the most commonly affected sites 
of suspected lesions (40%), followed by face and neck 
(37.5%), legs (20%) and other parts of the body (2.5%). 
Due to sand ﬂ y attack to the exposed body areas to have 
a blood meal, the most of the lesions appear in the hands, 
face, and legs, and upper parts of the body, which may be 
due to the outdoor sleeping on the terraces or yards with-
out using bed net during the summer. Previous report by 
Talari et al.7 confi rms this fi nding.22
Table 2. Body location of lesions among cutaneous 
leishmaniasis suspected patients in Iran
% Number of patients Lesion location
37.5 30 Face and neck
40 32 Hand and arm
20 16 Legs
2.5 2  Other parts of body
100 80 Total
Electrophoretic patterns of PCR products from 
genomic DNA
Electrophoresis patterns from each isolates were compared 
with reference strains of Iranian L. tropica and L. major. In 
this study, a single 620 bp band for identifi cation of L. ma-
jor and an 800 bp band for detection of L. tropica were evi-
denced. Thirty and twenty samples out of 50 were identifi ed as 
L. major (64%) and L. tropica (36%), respectively (Figure 2). 
Figure 2: Electrophoretic patterns of PCR products obtained 
from crude parasite genomic DNAs for Leishmania species 
detection 1; L. tropica, MHOM/IR/09/Mash-F 2; L. major 
MRHO/IR/75/ER, M; marker.
2 M 1
620 bp
800 bp
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According to PCR fi ndings, two strains of L. tropica and 
L. major are the causative agents of CL in Iran. Most of iso-
lates collected from patients infected in the Mashhad area 
and the majority of isolates from Kashan were character-
ized as L. tropica. These fi ndings lend support to previous 
publications about Leishmania species in Iran.12,24,25 Most of 
the isolates characterized as L. major species were collected 
from patients with a travel history to endemic foci in Shi-
raz, Chabahar and Sabzevar, as previously shown. Razmjou 
et al. found a 23.2% prevalence rate among 1,000 inhab-
itants of the three villages of Shiraz, with L. major being 
identifi ed in the majority of cases in rural areas of Shiraz.26 
However, these fi ndings have not been confi rmed by other 
researchers. In the study by Rahbarian et al. all isolates de-
tected by PCR method in Gonbad-e Qavus county, north 
Iran were of L. major.27 Parvizi et al (2010) also reported 
L. major in Natanz, Isfahan province in centre of Iran, in 
a rural ZCL focus.28 Conclusively, there are indication that 
Isfahan has been a major endemic focus of ZCL in Iran for 
several decades.24
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